Q3 2025 Holdings
Filed 2025-11-14 | 20 holdings | $135.9M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Adma Biologics Inc(ADMA) | COM | 000899104 | $35.4M | 2,412,542 | 26.0% |
| ELI Lilly & Co(LLY)Put | COM | 532457108 | $17.2M | 22,500 | 12.6% |
| Nvidia Corporation(NVDA)Put | COM | 67066G104 | $14.0M | 75,000 | 10.3% |
| ZAI LAB LTD(ZLAB) | ADR | 98887Q104 | $13.6M | 400,000 | 10.0% |
| Akero Therapeutics Inc(AKRO) | COM | 00973Y108 | $11.0M | 232,446 | 8.1% |
| Cellectis S A(CLLS) | SPON ADS | 15117K103 | $9.4M | 3,281,501 | 6.9% |
| Taysha Gene Therapies Inc(TSHA) | COM SHS | 877619106 | $5.9M | 1,800,556 | 4.3% |
| Assembly Biosciences Inc(ASMB) | COM NEW | 045396207 | $4.5M | 175,706 | 3.3% |
| NRX Pharmaceuticals Inc | *W EXP 05/24/202 | 629444118 | $4.5M | 3,000,000 | 3.3% |
| Ultragenyx Pharmaceutical in(RARE) | COM | 90400D108 | $4.1M | 135,000 | 3.0% |
| Aura Biosciences Inc(AURA) | COM | 05153U107 | $3.5M | 572,576 | 2.6% |
| Iovance Biotherapeutics Inc(IOVA) | COM | 462260100 | $3.3M | 1,500,000 | 2.4% |
| Sight Sciences Inc(SGHT) | COM | 82657M105 | $3.2M | 930,000 | 2.4% |
| Spyre Therapeutics Inc(SYRE) | COM NEW | 00773J202 | $1.7M | 100,000 | 1.2% |
| Praxis Precision Medicines I(PRAX) | COM NEW | 74006W207 | $1.7M | 31,500 | 1.2% |
| Oruka Therapeutics Inc(ORKA) | COM | 687604108 | $1.4M | 75,000 | 1.1% |
| Apogee Therapeutics Inc(APGE) | COM | 03770N101 | $1.4M | 35,000 | 1.0% |
| Replimune Group Inc(REPL)Call | COM | 76029N106 | $209.5K | 50,000 | 0.2% |
| Gamesquare Hldgs Inc(GAME) | COM | 36468G103 | $169.7K | 250,000 | 0.1% |
| Insmed Inc(INSM) | COM PAR $.01 | 457669307 | $22.8K | 158 | 0.0% |